BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 4156352)

  • 1. [Experience with long acting psychopharmaceutics in psychiatric hospitals].
    Reimer F
    Int Pharmacopsychiatry; 1974; 9(4):245-7. PubMed ID: 4156352
    [No Abstract]   [Full Text] [Related]  

  • 2. Suicidal risk in the treatment of outpatient schizophrenics with long-acting neuroleptics.
    Niturad A; Nicholschi-Oproiu L
    Agressologie; 1978; 19(C):145-8. PubMed ID: 35993
    [No Abstract]   [Full Text] [Related]  

  • 3. [Pharmaceutical characteristics of depot neuroleptics. Their use and efficacy in the psychiatric clinic].
    Mungiu OC; Chiriţă V; Boişteanu P; Mungiu A; Cosmovici N; Pirozynski T
    Rev Med Chir Soc Med Nat Iasi; 1988; 92(1):43-7. PubMed ID: 2899341
    [No Abstract]   [Full Text] [Related]  

  • 4. Some aspects of the French contribution during the past ten years to the study and use of injectable long-acting neuroleptics.
    Lambert PA; Guinot G; Chabannes JP
    Acta Psychiatr Belg; 1981; 81(2):103-14. PubMed ID: 6117180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Depot preparations in psychiatry].
    Gunby B
    Tidsskr Nor Laegeforen; 1974 Jan; 94(3):176-7. PubMed ID: 4150719
    [No Abstract]   [Full Text] [Related]  

  • 6. New drug development in France and French-speaking countries. Short and long acting neuroleptics.
    Deniker P; Ginestet D; Peron-Magnan P
    Dis Nerv Syst; 1974 Jul; 35(7 Pt. 2):18-20. PubMed ID: 17894096
    [No Abstract]   [Full Text] [Related]  

  • 7. [5 years' experience with prolonged-action neuroleptics].
    Lopez-Ibor Aliño JM; Tabares Pujante J
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1973; 1(5):721-31. PubMed ID: 4150175
    [No Abstract]   [Full Text] [Related]  

  • 8. [Experience with leptril therapy for preschool children].
    Semenovskaia EI; Rozengauz RA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1973; 73(10):1579-82. PubMed ID: 4149525
    [No Abstract]   [Full Text] [Related]  

  • 9. The pharmacology and therapeutic application of the phenothiazines.
    Rivera-Calimlim L
    Ration Drug Ther; 1977 Apr; 11(4):1-8. PubMed ID: 16316
    [No Abstract]   [Full Text] [Related]  

  • 10. Ethical use of long-acting medications in the treatment of severe and persistent mental illnesses.
    Roberts LW; Geppert CM
    Compr Psychiatry; 2004; 45(3):161-7. PubMed ID: 15124145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-acting drug treatment in overall psychiatric management.
    Capstick N
    Dis Nerv Syst; 1970 Sep; 31():Suppl:15-7. PubMed ID: 5476355
    [No Abstract]   [Full Text] [Related]  

  • 12. Shaping up the depot.
    Day J; Henderson B; Butterworth T
    Nurs Times; 1995 Nov 1-7; 91(44):51-4. PubMed ID: 7501527
    [No Abstract]   [Full Text] [Related]  

  • 13. Sex differences in long-term adverse effects of phenothiazines.
    Lehmann HE; Ban TA
    Adv Biochem Psychopharmacol; 1974; 9(0):249-54. PubMed ID: 4151763
    [No Abstract]   [Full Text] [Related]  

  • 14. An atypical long-acting injectable antipsychotic: implications for pharmacotherapy of schizophrenia.
    Dursun S
    J Psychopharmacol; 2005 Sep; 19(5 Suppl):3-4. PubMed ID: 16144780
    [No Abstract]   [Full Text] [Related]  

  • 15. Impractical features of long-acting risperidone.
    Amdur MA
    Psychiatr Serv; 2004 Dec; 55(12):1443; author reply 1443-4. PubMed ID: 15572577
    [No Abstract]   [Full Text] [Related]  

  • 16. Psychiatric drugs and trends: review of the phenothiazines. 1.
    Dembicki EL
    J Psychiatr Nurs Ment Health Serv; 1974; 12(3):47-8. PubMed ID: 4151849
    [No Abstract]   [Full Text] [Related]  

  • 17. Piperacetazine study in state hospital patients.
    del Portillo L
    J Med Assoc Ga; 1974 Dec; 63(12):465-7. PubMed ID: 4154960
    [No Abstract]   [Full Text] [Related]  

  • 18. Symposium on long-acting phenothiazines in psychiatry. Introduction.
    Cole JO
    Dis Nerv Syst; 1970 Sep; 31():Suppl:5. PubMed ID: 5476360
    [No Abstract]   [Full Text] [Related]  

  • 19. Use of long-acting risperidone in psychiatric disorders: focus on efficacy, safety and cost-effectiveness.
    Keith S
    Expert Rev Neurother; 2009 Jan; 9(1):9-31. PubMed ID: 19102665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and efficacy of long-acting risperidone in schizophrenia: a 12-week, multicenter, open-label study in stable patients switched from typical and atypical oral antipsychotics.
    Lindenmayer JP; Eerdekens E; Berry SA; Eerdekens M
    J Clin Psychiatry; 2004 Aug; 65(8):1084-9. PubMed ID: 15323593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.